Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-24-000079
Filing Date
2024-09-17
Accepted
2024-09-17 17:11:56
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1726607510.html 4  
1 FORM 4 wk-form4_1726607510.xml 4 7087
  Complete submission text file 0001662579-24-000079.txt   8575
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEON THERAPEUTICS, INC. 40 ERIE ST., SUITE 110 CAMBRIDGE MA 02139
Business Address
Siegel Jolie (Reporting) CIK: 0001768223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 241305290